Philipp Bartko
Overview
Explore the profile of Philipp Bartko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
180
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao M, Calabretta R, Binder P, Yu J, Jiang Z, Nitsche C, et al.
Eur J Nucl Med Mol Imaging
. 2024 Nov;
52(3):1073-1082.
PMID: 39586845
Purpose: To evaluate right ventricular (RV) uptake measured by quantitative [Tc]Tc-DPD SPECT/CT to investigate its role in predicting and evaluating prognosis and therapeutic outcomes in patients with transthyretin amyloid cardiomyopathy...
2.
Dreyfus J, Juarez-Casso F, Sala A, Carnero-Alcazar M, Eixeres-Esteve A, Bohbot Y, et al.
Eur Heart J
. 2024 Aug;
45(42):4512-4522.
PMID: 39212387
Background And Aims: Severe tricuspid regurgitation is associated with increased mortality rates, but benefit of its correction and ideal timing are not clearly determined. This study aimed to identify patient...
3.
Duca F, Mascherbauer K, Dona C, Koschutnik M, Binder C, Nitsche C, et al.
Obesity (Silver Spring)
. 2024 Aug;
32(9):1670-1679.
PMID: 39192763
Objective: Epicardial adipose tissue (EAT) quantity is associated with poor cardiovascular outcomes. However, the quality of EAT may be of incremental prognostic value. Cardiac magnetic resonance (CMR) is the gold...
4.
Demirel C, Hengstenberg C, Bartko P
MMW Fortschr Med
. 2024 Jul;
166(12):44-47.
PMID: 38995585
No abstract available.
5.
Wurm R, Prausmuller S, Ponleitner M, Spinka G, Weidenhammer A, Arfsten H, et al.
JACC Heart Fail
. 2024 Jun;
12(6):1073-1085.
PMID: 38839151
Background: Cognitive impairment is prevalent in patients with heart failure with reduced ejection fraction (HFrEF), affecting self-care and outcomes. Novel blood-based biomarkers have emerged as potential diagnostic tools for neurodegeneration....
6.
Dreyfus J, Galloo X, Taramasso M, Heitzinger G, Benfari G, Kresoja K, et al.
Eur Heart J
. 2023 Aug;
45(8):586-597.
PMID: 37624856
Background And Aims: Benefit of tricuspid regurgitation (TR) correction and timing of intervention are unclear. This study aimed to compare survival rates after surgical or transcatheter intervention to conservative management...
7.
Kerbel T, Uyanik-Unal K, Mach M, Bartunek A, Gokler J, Osorio E, et al.
Eur J Cardiothorac Surg
. 2023 May;
63(6).
PMID: 37255327
Objectives: Tricuspid regurgitation (TR) in patients who had heart transplants is associated with poor outcome. The increased risk for surgical and postoperative complications might be reduced in these vulnerable patients...
8.
Kreidel F, Frank D, Bartko P
JACC Cardiovasc Interv
. 2023 May;
16(10):1173-1175.
PMID: 37225287
No abstract available.
9.
Kerbel T, Mach M, Bartunek A, Bartko P, Andreas M
JACC Case Rep
. 2023 Apr;
12:101775.
PMID: 37091059
Heterotopic caval valve implantation may be a reasonable option for alleviating symptoms in select high-risk patients with recurrent tricuspid regurgitation after failed interventional tricuspid valve repair. However, altered right atrial...
10.
Dannenberg V, Koschutnik M, Dona C, Nitsche C, Spinka G, Heitzinger G, et al.
Eur J Clin Invest
. 2023 Jan;
53(6):e13961.
PMID: 36710528
Background: Mitral- and tricuspid regurgitation are associated with significant morbidity and mortality and are increasingly treated interventionally. CardioMEMS is a transcutaneously implanted pressure sensor placed in the pulmonary artery that...